Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate tablets, 5 mg,cll

Description

This generic medication, approved under ANDA207388 by Alvogen Inc., contains a combination of amphetamine salts (dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate) in oral tablet form. It's a Schedule II controlled substance, available in strengths equivalent to 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, 20 mg, and 30 mg of amphetamine, used as a central nervous system stimulant. This information was generated using AI and is provided for informational and research purposes only.

Resources

Name Format Description Link
21 Access the FDA dataset for Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate tablets, 5 mg,cll — ANDA 207388 submitted by Mylan Institutional LLC https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207388

Tags

  • health-care
  • public-health
  • prescription-drugs
  • pharmaceuticals
  • medications

Topics

Categories